The Journal of Pain
Volume 10, Issue 2 , Pages 131-146.e5 , February 2009

Opioids for Chronic Noncancer Pain: Prediction and Identification of Aberrant Drug-Related Behaviors: A Review of the Evidence for an American Pain Society and American Academy of Pain Medicine Clinical Practice Guideline

  • Roger Chou

      Affiliations

    • The Oregon Evidence-based Practice Center, Department of Medicine, Department of Medical Informatics and Clinical Epidemiology, Oregon Health and Science University, Portland, Oregon
    • Corresponding Author InformationAddress reprint requests to Dr Roger Chou, 3181 SW Sam Jackson Park Road, Mail Code BICC, Portland, OR 97239.
    • ,
  • Gilbert J. Fanciullo

      Affiliations

    • Pain Management Center, Department of Anesthesiology, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire
    • ,
  • Perry G. Fine

      Affiliations

    • Pain Research Center, Department of Anesthesiology, University of Utah, Salt Lake City, Utah
    • ,
  • Christine Miaskowski

      Affiliations

    • Department of Physiological Nursing, School of Nursing, University of California, San Francisco
    • ,
  • Steven D. Passik

      Affiliations

    • Department of Psychiatry and Behavioral Sciences, Memorial Sloan-Kettering Cancer Center, New York, New York
    • ,
  • Russell K. Portenoy

      Affiliations

    • Department of Pain Medicine and Palliative Care, Beth Israel Medical Center, New York, New York

References 

  1. Adams LL, Gatchel RJ, Robinson RC, Polatin P, Gajraj N, Deschner M, et al. Development of a self-report screening instrument for assessing potential opioid medication misuse in chronic pain patients. J Pain Symptom Manage. 2004;27:440–459
  2. Akbik H, Butler SF, Budman SH, Fernandez K, Katz NP, Jamison RN. Validation and clinical application of the screener and opioid assessment for patients with pain (SOAPP). J Pain Symptom Manage. 2006;32:287–293
  3. Allan L, Richarz U, Simpson K, Slappendel R. Transdermal fentanyl versus sustained release oral morphine in strong-opioid naive patients with chronic low back pain. Spine. 2005;30:2484–2490
  4. Atluri SL, Sudarshan G. Development of a screening tool to detect the risk of inappropriate prescription opioid use in patients with chronic pain. Pain Physician. 2004;7:333–338
  5. Belgrade MJ, Schamber CD, Lindgren BR. The DIRE score: Predicting outcomes of opioid prescribing for chronic pain. J Pain. 2006;7:671–681
  6. British Pain Society: Recommendations for the appropriate use of opioids for persistent non-cancer pain (the first revised edition). London: The British Pain Society, March 2005
  7. Butler SF, Budman SH, Fernandez K, Jamison RN. Validation of a screener and opioid assessment measure for patients with chronic pain. Pain. 2004;112:65–75
  8. Butler SF, Budman SH, Fernandez KC, Houle B, Benoit C, Katz N, et al. Development and validation of the current opioid misuse measure. Pain. 2007;130:144–156
  9. Butler SF, Fernandez K, Benoit C, Budman SH, Jamison RN. Validation of the revised screener and opioid assessment for patients with pain (SOAPP-R). J Pain. 2008;9:360–372
  10. Caudill-Slosberg MA, Schwartz LM, Woloshin S. Office visits and analgesic prescriptions for musculoskeletal pain in US: 1980 vs 2000. Pain. 2004;109:514–519
  11. Chabal C, Erjavec MK, Jacobson L, Mariano A, Chaney E. Clinical criteria, incidence, and predictors. Clin J Pain. 1997;13:150–155
  12. Chou C, Fanciullo G, Fine P, Adler J, Ballantyne J, Davies P, et al. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain. 2009;10:113–130
  13. Chou R, Huffman L. The use of opioids for chronic non-cancer pain: Evidence review. Glenview, IL: American Pain Society, 2009
  14. Coambs R. A new screening instrument for identifying potential opioid abusers in the management of chronic nonmalignant pain with general medical practice. Pain Res Manag. 1996;1:155–162
  15. Compton P, Darakjian J, Miotto K. Screening for addiction in patients with chronic pain and “problematic” substance use: Evaluation of a pilot assessment tool. J Pain Symptom Manage. 1998;16:355–363
  16. Edlund MJ, Steffick D, Hudson T, Harris KM, Sullivan M. Risk factors for clinically recognized opioid abuse and dependence among veterans using opioids for chronic non-cancer pain. Pain. 2007;129:355–362
  17. Fishbain DA, Cutler RB, Rosomoff HL, Rosomoff RS. Validity of self-reported drug use in chronic pain patients. Clin J Pain. 1999;15:184–191
  18. Fishman SM, Wilsey B, Yang J, Reisfield GM, Bandman TB, Borsook D. Adherence monitoring and drug surveillance in chronic opioid therapy. J Pain Sympt Manage. 2000;20:293–307
  19. Fleming MF, Balousek SL, Klessig CL, Mundt MP, Brown DD. Substance use disorders in a primary care sample receiving daily opioid therapy. J Pain. 2007;8:573–582
  20. Friedman R, Li V, Mehrotra D. Treating pain patients at risk: Evaluation of a screening tool in opioid-treated pain patients with and without addiction. Pain Med. 2003;4:182–185
  21. Furlan AD, Sandoval JA, Mailis-Gagnon A, Tunks E. Opioids for chronic noncancer pain: A meta-analysis of effectiveness and side effects. CMAJ. 2006;174:1589–1594
  22. Graziotti P, Goucke R. The use of oral opioids in patients with chronic nonmalignant pain: Management strategies. Med J Austr. 1997;167:30–34
  23. Gustorff B. Intravenous opioid testing in patients with chronic non-cancer pain. Eur J Pain. 2005;9:123–125
  24. Hariharan J, Lamb G, Neuner J. Long-term opioid contract use for chronic pain management in primary care practice: A five year experience. J Gen Intern Med. 2007;22:485–490
  25. Harris RP, Helfand M, Woolf SH, Lohr KN, Mulrow CD, Teutsch SM, et al. Current methods of the third US Preventive Services Task Force. Am J Prev Med. 2001;20:21–35
  26. Hojsted J, Sjogren P. Addiction to opioids in chronic pain patients: A literature review. Eur J Pain. 2007;11:490–518
  27. Holmes CP, Gatchel RJ, Adams LL, Stowell AW, Hatten A, Noe C, et al. An opioid screening instrument: Long-term evaluation of the utility of the pain medication questionnaire. Pain Pract. 2006;6:74–88
  28. Ives TJ, Chelminski PR, Hammett-Stabler CA, Malone RM, Perhac JS, Potisek NM, et al. Predictors of opioid misuse in patients with chronic pain: A prospective cohort study. BMC Health Serv Res. 2006;6:46
  29. Jaeschke R. Users' guide to the medical literature, III: How to use an article about diagnostic test, B: What are the results and will they help me in caring for my patients?. JAMA. 1994;271:703–707
  30. Jaeschke R, Guyatt GH, Sackett DL. Users' guides to the medical literature, III: How to use an article about a diagnostic test, B: What are the results and will they help me in caring for my patients?. JAMA. 1994;271:703–707
  31. Jovey RD, Ennis J, Gardner-Nix J, Goldman B, Hays H, Lynch M, Moulin D: Use of opioid analgesics for the treatment of chronic noncancer pain: A consensus statement and guidelines from the Canadian Pain Society, 2002. Pain Res Manag 8:3A–28A, 2003
  32. Kalman S, Osterberg A, Sorensen J, Boivie J, Bertler A. Morphine responsiveness in a group of well-defined multiple sclerosis patients: A study with iv morphine. Eur J Pain. 2002;6:69–80
  33. Kalso E, Allan L, Dellemijn PL, Faura CC, Ilias WK, Jensen TS, et al. European Federation of Chapters of the International Association for the Study of Pain. Recommendations for using opioids in chronic non-cancer pain. Eur J Pain. 2003;7:381–386
  34. Kalso E, Edwards JE, Moore RA, McQuay HJ. Opioids in chronic non-cancer pain: Systematic review of efficacy and safety. Pain. 2004;112:372–380
  35. Katz N, Fanciullo GJ. Role of urine toxicology testing in the management of chronic opioid therapy. Clin J Pain. 2002;18:S76–S82
  36. Lijmer JG, Mol BW, Heisterkamp S, Bonsel GJ, Prins MH, van der Meulen JH, et al. Empirical evidence of design-related bias in studies of diagnostic tests. JAMA. 1999;282:1061–1066
  37. Mahowald ML, Singh JA, Majeski P. Opioid use by patients in an orthopedics spine clinic. Arthritis Rheum. 2005;52:312–321
  38. Manchikanti L, Cash KA, Damron KS, Manchukonda R, Pampati V, McManus CD. Controlled substance abuse and illicit drug use in chronic pain patients: An evaluation of multiple variables. Pain Physician. 2006;9:215–225
  39. Manchikanti L, Giordano J, Boswell MV, Fellows B, Manchukonda R, Pampati V. Psychological factors as predictors of opioid abuse and illicit drug use in chronic pain patients. J Opioid Manage. 2007;3:89–100
  40. Manchikanti L, Manchukonda R, Damron KS, Brandon D, McManus CD, Cash K. Does adherence monitoring reduce controlled substance abuse in chronic pain patients?. Pain Physician. 2006;9:57–60
  41. Manchikanti L, Manchukonda R, Pampati V, Damron KS, Brandon DE, Cash KA, et al. Does random urine drug testing reduce illicit drug use in chronic pain patients receiving opioids?. Pain Physician. 2006;9:123–129
  42. Manchikanti L, Pampati V, Damron KS, Beyer CD, Barnhill RC. Prevalence of illicit drug use in patients without controlled substance abuse in interventional pain management. Pain Physician. 2003;6:173–178
  43. Manchikanti L, Pampati V, Damron KS, McManus CD. Evaluation of variables in illicit drug use: Does a controlled substance abuse screening tool identify illicit drug use?. Pain Physician. 2004;7:71–75
  44. Maruta T, Swanson DW, Finlayson RE. Drug abuse and dependency in patients with chronic pain. Mayo Clin Proc. 1979;54:241–244
  45. McGinn TG, Guyatt GH, Wyer PC, Naylor CD, Stiell IG, Richardson WS. Users' guides to the medical literature XXII: How to use articles about clinical decision rules. JAMA. 2000;284:79–84
  46. Michna E, Jamison RN, Pham L-D, Ross EL, Janfaza D, Nedeljkovic SS, et al. Urine toxicology screening among chronic pain patients on opioid therapy: frequency and predictability of abnormal findings. Clin J Pain. 2007;23:173–179
  47. Michna E, Ross EL, Hynes WL, Nedeljkovic SS, Soumekh S, Janfaza D, et al. Predicting aberrant drug behavior in patients treated for chronic pain: importance of abuse history. J Pain Sympt Manage. 2004;28:250–258
  48. Moher D, Pham B, Klassen TP, Schulz KF, Berlin JA, Jadad AR, et al. What contributions do languages other than English make on the results of meta-analyses?. J Clin Epidemiol. 2000;53:964–972
  49. Moore RA, McQuay HJ. Prevalence of opioid adverse events in chronic non-malignant pain: Systematic review of randomised trials of oral opioids. Arthritis Res Ther. 2005;7:R1046–R1051
  50. Noble M, Tregear SJ, Treadwell JR, Schoelles K. Long-term opioid therapy for chronic noncancer pain: A systematic review and meta-analysis of efficacy and safety. J Pain Sympt Manage. 2008;35:214–228
  51. Passik SD, Kirsh KL. The need to identify predictors of aberrant drug-related behavior and addiction in patients being treated with opioids for pain. Pain Med. 2003;4:186–189
  52. Passik SD, Kirsh KL, Whitcomb L, Portenoy RK, Katz NP, Kleinman L, et al. A new tool to assess and document pain outcomes in chronic pain patients receiving opioid therapy. Clin Ther. 2004;26:552–561
  53. Passik SD, Kirsh KL, Whitcomb L, Schein JR, Kaplan MA, Dodd SL, et al. Monitoring outcomes during long-term opioid therapy for noncancer pain: Results with the Pain Assessment and Documentation Tool. J Opioid Manag. 2005;1:257–266
  54. Phillips JE, Bogema S, Fu P, Furmaga W, Wu AHB, Zic V, et al. Signify ER Drug Screen Test evaluation: Comparison to triage drug of abuse panel plus tricyclic antidepressants. Clin Chim Acta. 2003;328:31–38
  55. Portenoy RK, Farrar JT, Backonja M-M, Cleeland CS, Yang K, Friedman M, et al. Long-term use of controlled-release oxycodone for noncancer pain: Results of a 3-year registry study. Clin J Pain. 2007;23:287–299
  56. Portenoy RK. Opioid therapy for chronic nonmalignant pain: A review of the critical issues. J Pain Symptom Manage. 1996;11:203–217
  57. Reid MC, Engles-Horton LL, Weber MB, Kerns RD, Rogers EL, O'Connor PG. Use of opioid medications for chronic noncancer pain syndromes in primary care. J Gen Intern Med. 2002;17:173–179
  58. Reilly BM, Evans AT. Translating clinical research into clinical practice: Impact of using prediction rules to make decisions. Ann Intern Med. 2006;144:201–209
  59. Schieffer BM, Pham Q, Labus J, Baria A, Van Vort W, Davis P, et al. Pain medication beliefs and medication misuse in chronic pain. J Pain. 2005;6:620–629
  60. Sorensen J, Kalman S, Tropp H, Bengtsson M. Can a pharmacological pain analysis be used in the assessment of chronic low back pain?. Eur Spine J. 1996;5:236–242
  61. Management of Opioid Therapy for Chronic Pain Working Group: VA/DoD Clinical Practical Guidelines for the management of opioid therapy for chronic pain. Contract No: V101(93)P-1633(version 1.0), 2003
  62. Toma M, McAlister FA, Bialy L, Adams DB, Vandermeer B, Armstrong PW. Transition from meeting abstract to full-length journal article for randomized controlled trials. JAMA. 2006;295:1281–1287
  63. Turk DC, Swanson KS, Gatchel RJ. Predicting opioid misuse by chronic pain patients: A systematic review and literature synthesis. Clin J Pain. 2008;24:497–508
  64. Wasan AD, Butler SF, Budman SH, Benoit C, Fernandez K, Jamison RN. Psychiatric history and psychologic adjustment as risk factors for aberrant drug-related behavior among patients with chronic pain. Clin J Pain. 2007;23:307–315
  65. Wasan AD, Davar G, Jamison R. The association between negative affect and opioid analgesia in patients with discogenic low back pain. Pain. 2005;117:450–461
  66. Webster LR, Webster RM. Predicting aberrant behaviors in opioid-treated patients: Preliminary validation of the Opioid Risk Tool. Pain Med. 2005;6:432–442
  67. Whiting P, Rutjes A, Reitsma J, Glas A, Bossuyt P, Kleijnen J. Sources of variation and bias in studies of diagnostic accuracy: A systematic review. Ann Intern Med. 2004;140:189–202
  68. Wu SM, Compton P, Bolus R, Schieffer B, Pham Q, Baria A, et al. The addiction behaviors checklist: Validation of a new clinician-based measure of inappropriate opioid use in chronic pain. J Pain Symp Manage. 2006;32:342–351

 Editor's Note: The American Pain Society and the American Academy of Pain Medicine present this second of 3 articles in this 3-part report as a guideline for opioid treatment of noncancer pain.

 This article is based on research conducted at the Oregon Evidence-based Practice Center with funding from the American Pain Society (APS). The authors are solely responsible for the content of this article and the decision to submit for publication. No statement in this article should be construed as an official position of the APS or the American Academy of Pain Medicine. The authors have no known or potential conflicts of interest to declare.

PII: S1526-5900(08)00832-8

doi: 10.1016/j.jpain.2008.10.009

The Journal of Pain
Volume 10, Issue 2 , Pages 131-146.e5 , February 2009

Article Tools